Tanshinone IIA protects PC12 cells from β-amyloid25–35-induced apoptosis via PI3K/Akt signaling pathway
- 8 February 2012
- journal article
- Published by Springer Science and Business Media LLC in Molecular Biology Reports
- Vol. 39 (6), 6495-6503
- https://doi.org/10.1007/s11033-012-1477-3
Abstract
For the aging populations of any nation, Dementia is becoming a primary problem and Alzheimer’s dementia (AD) is the most common type. However, until now, there is no effective treatment for AD. Tanshinone IIA (Tan IIA) has been reported for neuroprotective potential to against amyloid β peptides (Aβ)-induced cytotoxicity in the rat pheochromocytoma cell line PC-12, which is widely used as AD research model, but the mechanism still remains unclear. To investigate the effect of Tan IIA and the possible molecular mechanism in the apoptosis of PC12 cells, we induced apoptosis in PC12 cells with β-amyloid25–35, and treated cells with Tan IIA. After 24 h treatment, we found that Tan IIA increased the cell viability and reduced the number of apoptotic cells induced by Aβ25–35. However, neuroprotection of Tan IIA was abolished by PI3K inhibitor LY294002. Meanwhile, Treatment with lithium chloride, a phosphorylation inhibitor of GSK3β, which is a downstream target of PI3K/Akt, can block Aβ25–35-induced cell apoptosis in a Tan IIA-like manner. Our findings suggest that Tan IIA is an effective neuroprotective agent and a viable candidate in AD therapy and PI3K/Akt activation and GSK3β phosphorylation are involved in the neuroprotection of Tan IIA.Keywords
This publication has 41 references indexed in Scilit:
- mTORC2 Protein-mediated Protein Kinase B (Akt) Serine 473 Phosphorylation Is Not Required for Akt1 Activity in Human PlateletsPublished by Elsevier BV ,2011
- Autism, Alzheimer disease, and fragile XNeurology, 2011
- The sirtuin pathway in ageing and Alzheimer disease: mechanistic and therapeutic considerationsThe Lancet Neurology, 2011
- Overexpression of Glutaminyl Cyclase, the Enzyme Responsible for Pyroglutamate Aβ Formation, Induces Behavioral Deficits, and Glutaminyl Cyclase Knock-out Rescues the Behavioral Phenotype in 5XFAD MicePublished by Elsevier BV ,2011
- Amino Acids Activate Mammalian Target of Rapamycin Complex 2 (mTORC2) via PI3K/Akt SignalingJournal of Biological Chemistry, 2011
- GSK3 and Alzheimer’s disease: facts and fiction…Frontiers in Molecular Neuroscience, 2011
- D1 and D2 dopamine receptors differentially mediate the activation of phosphoproteins in the striatum of amphetamine-sensitized ratsPsychopharmacology, 2010
- Mu-Opioid Receptors Transiently Activate the Akt-nNOS Pathway to Produce Sustained Potentiation of PKC-Mediated NMDAR-CaMKII SignalingPLOS ONE, 2010
- Beta-amyloid toxicity and reversal in embryonic rat septal neuronsNeuroscience Letters, 2007
- Preconditioning Doses of NMDA Promote Neuroprotection by Enhancing Neuronal ExcitabilityJournal of Neuroscience, 2006